ConductScience.org, home

Paper3733693

Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems.

Rauch J and 7 others. J Biol Chem, 1986. Cited by 143 papers, by iCite.

Cite this record

ConductScience Library. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. Papers, record 3733693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3733693

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems.
PubMed
Journal
J Biol Chem
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
143
iCite
Relative citation ratio, by iCite
6.17
iCite
Revised in PubMed
2021-02-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rauch JJ
2Tannenbaum MM
3Tannenbaum HH
4Ramelson HH
5Cullis PRP R
6Tilcock CPC P
7Hope MJM J
8Janoff ASA S

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntibodiesMajor topic
HybridomasMajor topic
Lupus Erythematosus, SystemicMajor topic
PhospholipidsMajor topic
Autoantibodies
Binding, Competitive
Blood Coagulation Tests
Humans
Magnetic Resonance Spectroscopy
Partial Thromboplastin Time
Phosphatidylcholines
Phosphatidylethanolamines
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.

PMIDTitleJournalYearIn PapersSource
9294215The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins).Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9294215PubMed
8613497The antiphospholipid-protein syndrome.J Clin Immunol1995https://conductscience.org/library/papers/8613497PubMed
7814631On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies.J Clin Invest1995https://conductscience.org/library/papers/7814631PubMed
7586693Interactions and molecular structure of cardiolipin and beta 2-glycoprotein 1 (beta 2-GP1).Clin Exp Immunol1995https://conductscience.org/library/papers/7586693PubMed
7536353Antigenic specificities of "antiphospholipid" autoantibodies.Springer Semin Immunopathol1994https://conductscience.org/library/papers/7536353PubMed
3392165IgG but not IgM anti-phospholipid antibody binding is temperature dependent.J Clin Immunol1988https://conductscience.org/library/papers/3392165PubMed
3196084Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.Ann Rheum Dis1988https://conductscience.org/library/papers/3196084PubMed
3162316Antibodies to cholesterol.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3162316PubMed
2820640Lupus anticoagulant activities of murine monoclonal antibodies to liposomal phosphatidylinositol phosphate.Clin Exp Immunol1987https://conductscience.org/library/papers/2820640PubMed
2467768Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes.Clin Exp Immunol1989https://conductscience.org/library/papers/2467768PubMed
2357843Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis.Clin Exp Immunol1990https://conductscience.org/library/papers/2357843PubMed
2211960Lysophosphatidylethanolamine is the antigen to which apparent antibody to phosphatidylethanolamine binds.J Clin Immunol1990https://conductscience.org/library/papers/2211960PubMed
2199094Lessons about autoantibody specificity in systemic lupus erythematosus from animal models.Clin Exp Immunol1990https://conductscience.org/library/papers/2199094PubMed
2168305The antiphospholipid antibody dilemma.Clin Rheumatol1990https://conductscience.org/library/papers/2168305PubMed
2112249Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2112249PubMed
2044227Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation.Clin Exp Immunol1991https://conductscience.org/library/papers/2044227PubMed
1694860Fatty acid chain is a critical epitope for antiphospholipid antibody.J Clin Immunol1990https://conductscience.org/library/papers/1694860PubMed
1372614Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein.J Clin Immunol1992https://conductscience.org/library/papers/1372614PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3733693

GET https://conductscience.org/api/papers/v1/3733693/authors